E0 ConsensusPreliminaryPEM unclearMeta-AnalysisPeer-reviewedMachine draft
Meta analysis of Chronic Fatigue Syndrome through integration of clinical, gene expression, SNP and proteomic data.
Pihur, Vasyl, Datta, Somnath, Datta, Susmita · Bioinformation · 2011 · DOI
Quick Summary
Researchers combined multiple types of biological data from ME/CFS patients and healthy controls to identify genes that may contribute to ME/CFS and its severity. They found 11 genes of potential importance, with one gene called WASF3 standing out as possibly influencing fatigue through a specific cellular pathway in the brain.
Why It Matters
This work represents an important multi-omics approach to understanding ME/CFS molecular mechanisms. Identifying genes like WASF3 and specific signaling pathways (p38 MAPK) provides potential targets for future diagnostic and therapeutic development, moving beyond single-gene or single-platform analyses.
Observed Findings
- Eleven genes identified with potential importance to ME/CFS pathophysiology
- WASF3 gene highlighted as a candidate regulator of brain cytokines and fatigue mechanisms
- Two SNPs associated with symptom severity were examined in gene networks
- Ten protein features showed discriminative power between patient and control groups
- Common genes identified by two independent network methods provided added validation
Inferred Conclusions
- WASF3 may play a role in regulating cytokine-mediated fatigue through the p38 MAPK signaling pathway
- Integrated multi-omics approaches can identify gene networks more reliably than single-platform analyses
- Certain genes and proteins show promise as biological markers associated with ME/CFS symptom severity
Remaining Questions
- What are the functional mechanisms by which WASF3 and other identified genes contribute to ME/CFS pathophysiology?
- How well do these findings replicate in independent patient cohorts with standardized diagnostic criteria?
- Can any of the identified genes or proteins serve as practical biomarkers for diagnosis or prognosis?
What This Study Does Not Prove
This study does not prove that WASF3 or the identified genes directly cause ME/CFS—it identifies associations that require functional validation in laboratory and clinical studies. Meta-analyses cannot establish causation, and the findings must be replicated in independent cohorts with clearly defined case definitions before clinical application.
Tags
Symptom:Fatigue
Biomarker:CytokinesGene ExpressionBlood Biomarker
Method Flag:Small SampleExploratory Only
Metadata
- DOI
- 10.6026/97320630006120
- PMID
- 21584188
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →